Pembrolizumab Plus Olaparib for Patients With Previously Treated and Biomarker-Unselected Metastatic Castration-Resistant Prostate Cancer: The Randomized, Open-Label, Phase III KEYLYNK-010 Trial
Antonarakis, Emmanuel S, Park, Se Hoon, Goh, Jeffrey C, Shin, Sang Joon, Lee, Jae Lyun, Mehra, Niven, McDermott, Ray, Sala-Gonzalez, Núria, Fong, Peter C, Greil, Richard, Retz, Margitta, Sade, Juan Pablo, Yanez, Patricio, Huang, Yi-Hsiu, Begbie, Stephen D, Gafanov, Rustem Airatovich, De Santis, Maria, Rosenbaum, Eli, Kolinsky, Michael P, Rey, Felipe, Chiu, Kun-Yuan, Roubaud, Guilhem, Kramer, Gero, Sumitomo, Makoto, Massari, Francesco, Suzuki, Hiroyoshi, Qiu, Ping, Zhang, Jinchun, Kim, Jeri, Poehlein, Christian H, Yu, Evan Y
Published in Journal of clinical oncology (01.08.2023)
Published in Journal of clinical oncology (01.08.2023)
Get full text
Journal Article
Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study
Ciuleanu, Tudor, MD, Brodowicz, Thomas, MD, Zielinski, Christoph, Prof, Kim, Joo Hang, MD, Krzakowski, Maciej, Prof, Laack, Eckart, MD, Wu, Yi-Long, Prof, Bover, Isabel, MD, Begbie, Stephen, MD, Tzekova, Valentina, MD, Cucevic, Branka, MD, Pereira, Jose Rodrigues, MD, Yang, Sung Hyun, MD, Madhavan, Jayaprakash, MD, Sugarman, Katherine P, MD, Peterson, Patrick, PhD, John, William J, MD, Krejcy, Kurt, MD, Belani, Chandra P, Dr
Published in The Lancet (British edition) (24.10.2009)
Published in The Lancet (British edition) (24.10.2009)
Get full text
Journal Article
Docetaxel and dasatinib or placebo in men with metastatic castration-resistant prostate cancer (READY): a randomised, double-blind phase 3 trial
Araujo, John C, Dr, Trudel, Géralyn C, PhD, Saad, Fred, Prof, Armstrong, Andrew J, MD, Yu, Evan Y, MD, Bellmunt, Joaquim, MD, Wilding, George, Prof, McCaffrey, John, Prof, Serrano, Sergio V, MD, Matveev, Vsevolod B, Prof, Efstathiou, Eleni, MD, Oudard, Stephane, Prof, Morris, Michael J, MD, Sizer, Bruce, MBChB, Goebell, Peter J, MD, Heidenreich, Axel, Prof, de Bono, Johann S, Prof, Begbie, Stephen, MBBS, Hong, Jun H, MD, Richardet, Eduardo, MD, Gallardo, Enrique, MD, Paliwal, Prashni, PhD, Durham, Susan, BA, Cheng, Shinta, MD, Logothetis, Christopher J, Prof
Published in The lancet oncology (01.12.2013)
Published in The lancet oncology (01.12.2013)
Get full text
Journal Article
Health-Related Quality of Life in Metastatic, Hormone-Sensitive Prostate Cancer: ENZAMET (ANZUP 1304), an International, Randomized Phase III Trial Led by ANZUP
Stockler, Martin R, Martin, Andrew J, Davis, Ian D, Dhillon, Haryana M, Begbie, Stephen D, Chi, Kim N, Chowdhury, Simon, Coskinas, Xanthi, Frydenberg, Mark, Hague, Wendy E, Horvath, Lisa G, Joshua, Anthony M, Lawrence, Nicola J, Marx, Gavin M, McCaffrey, John, McDermott, Ray, McJannett, Margaret, North, Scott A, Parnis, Francis, Parulekar, Wendy R, Pook, David W, Reaume, M Neil, Sandhu, Shahneen, Tan, Alvin, Tan, Thean Hsiang, Thomson, Alastair, Vera-Badillo, Francisco, Williams, Scott G, Winter, Diana G, Yip, Sonia, Zhang, Alison Y, Zielinski, Robert R, Sweeney, Christopher J
Published in Journal of clinical oncology (10.03.2022)
Published in Journal of clinical oncology (10.03.2022)
Get full text
Journal Article
Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer
Davis, Ian D, Martin, Andrew J, Stockler, Martin R, Begbie, Stephen, Chi, Kim N, Chowdhury, Simon, Coskinas, Xanthi, Frydenberg, Mark, Hague, Wendy E, Horvath, Lisa G, Joshua, Anthony M, Lawrence, Nicola J, Marx, Gavin, McCaffrey, John, McDermott, Ray, McJannett, Margaret, North, Scott A, Parnis, Francis, Parulekar, Wendy, Pook, David W, Reaume, M. Neil, Sandhu, Shahneen K, Tan, Alvin, Tan, T. Hsiang, Thomson, Alastair, Tu, Emily, Vera-Badillo, Francisco, Williams, Scott G, Yip, Sonia, Zhang, Alison Y, Zielinski, Robert R, Sweeney, Christopher J
Published in The New England journal of medicine (11.07.2019)
Published in The New England journal of medicine (11.07.2019)
Get full text
Journal Article
Phase I, Open-Label, Dose-Escalation/Dose-Expansion Study of Lifirafenib (BGB-283), an RAF Family Kinase Inhibitor, in Patients With Solid Tumors
Desai, Jayesh, Gan, Hui, Barrow, Catherine, Jameson, Michael, Atkinson, Victoria, Haydon, Andrew, Millward, Michael, Begbie, Stephen, Brown, Michael, Markman, Ben, Patterson, William, Hill, Andrew, Horvath, Lisa, Nagrial, Adnan, Richardson, Gary, Jackson, Christopher, Friedlander, Michael, Parente, Phillip, Tran, Ben, Wang, Lai, Chen, Yunxin, Tang, Zhiyu, Huang, Wendy, Wu, John, Zeng, Dewan, Luo, Lusong, Solomon, Benjamin
Published in Journal of clinical oncology (01.07.2020)
Published in Journal of clinical oncology (01.07.2020)
Get full text
Journal Article
Testosterone suppression plus enzalutamide versus testosterone suppression plus standard antiandrogen therapy for metastatic hormone-sensitive prostate cancer (ENZAMET): an international, open-label, randomised, phase 3 trial
Sweeney, Christopher J, Martin, Andrew J, Stockler, Martin R, Cheung, Leanna, Chi, Kim N, Chowdhury, Simon, Frydenberg, Mark, Joshua, Anthony M, Lawrence, Nicola J, Marx, Gavin, McCaffrey, John, McDermott, Ray, McJannett, Margaret, North, Scott A, Parnis, Francis, Parulekar, Wendy, Pook, David W, Reaume, Martin Neil, Sandhu, Shahneen K, Tan, Alvin, Tan, Thean Hsiang, Thomson, Alastair, Vera-Badillo, Francisco, Williams, Scott G, Yip, Sonia, Zielinski, Robert R, Davis, Ian D, Abdi, Ehtesham, Bastick, Patricia, Begbie, Stephen, Blum, Robert, Briscoe, Karen, Brungs, Daniel, Bydder, Sean, Chittajallu, Bala Renuka, Cronk, Michelle, Cuff, Katharine, Davis, Ian D, Dowling, Anthony, Frydenberg, Mark, Horvath, Lisa, Hovey, Elizabeth, Joshua, Anthony, Karanth, Narayan, Kichenadasse, Ganessan, Krieger, Laurence, Marx, Gavin, Mathlum, Maitham, Nott, Louise, Otty, Zulfiquer, Parnis, Francis, Pook, David, Sandhu, Shahneen, Sewak, Sanjeev, Stevanovic, Amanda, Suder, Aneta, Tan, Hsiang, Torres, Javier, Troon, Simon, Underhill, Craig, Weickhardt, Andrew, Zielinski, Robert, Anan, Ghadeer, Booth, Chris, Campbell, Holly, Chi, Kim, Chin, Joseph, Chouinard, Edmond, Drachenberg, Darrel, Faghih, Amir, Finelli, Antonio, Hotte, Sebastien, North, Scott, Rassouli, Mohammad, Reaume, Neil, Rendon, Ricardo, Saad, Fred, Sadikov, Evgeny, Vigneault, Eric, Zalewski, Pawel, McCaffrey, John, McDermott, Ray, Morris, Patrick, O'Connor, Miriam, Donnellan, Paul, Edwards, Jim, Fong, Peter, Tan, Alvin, Chowdhury, Simon, Crabb, Simon, Khan, Omar, Khoo, Vincent, Macdonald, Graham, Payne, Heather, Robinson, Angus, Shamash, Jonathon, Staffurth, John, Thomas, Carys, Thomson, Alastair, Sweeney, Christopher J
Published in The lancet oncology (01.04.2023)
Published in The lancet oncology (01.04.2023)
Get full text
Journal Article
Overall Survival of Men with Metachronous Metastatic Hormone-sensitive Prostate Cancer Treated with Enzalutamide and Androgen Deprivation Therapy
Sweeney, Christopher J., Martin, Andrew J., Stockler, Martin R., Begbie, Stephen, Chi, Kim N., Chowdhury, Simon, Coskinas, Xanthi, Frydenberg, Mark, Hague, Wendy E., Horvath, Lisa G., Joshua, Anthony M., Lawrence, Nicola J., Marx, Gavin M., McCaffrey, John, McDermott, Ray, McJannett, Margaret, North, Scott A., Parnis, Francis, Parulekar, Wendy, Pook, David W., Reaume, M. Neil, Sandhu, Shahneen K., Tan, Alvin, Tan, Thean Hsiang, Thomson, Alastair, Tu, Emily, Vera-Badillo, Francisco, Williams, Scott G., Yip, Sonia, Zhang, Alison Y., Zielinski, Robert R., Davis, Ian D.
Published in European urology (01.09.2021)
Published in European urology (01.09.2021)
Get full text
Journal Article
Effects of a Structured Exercise Program on Physical Activity and Fitness in Colon Cancer Survivors: One Year Feasibility Results from the CHALLENGE Trial
Courneya, Kerry S, Vardy, Janette L, O'Callaghan, Christopher J, Friedenreich, Christine M, Campbell, Kristin L, Prapavessis, Harry, Crawford, Jennifer J, O'Brien, Patti, Dhillon, Haryana M, Jonker, Derek J, Chua, Neil S, Lupichuk, Sasha, Sanatani, Michael S, Gill, Sharlene, Meyer, Ralph M, Begbie, Stephen, Bonaventura, Tony, Burge, Matthew E, Turner, Jane, Tu, Dongsheng, Booth, Christopher M
Published in Cancer epidemiology, biomarkers & prevention (01.06.2016)
Published in Cancer epidemiology, biomarkers & prevention (01.06.2016)
Get full text
Journal Article
Patient-reported outcomes (PROs) in KEYLYNK-010: Pembrolizumab (pembro) plus olaparib (ola) vs abiraterone acetate (abi) or enzalutamide (enza) for patients (pts) with previously treated metastatic castration-resistant prostate cancer (mCRPC)
Mehra, Niven, Antonarakis, Emmanuel S., Park, Se Hoon, Goh, Jeffrey C., McDermott, Raymond S., Sala González, Nuria, Fong, Peter C.C., Greil, Richard, De Santis, Maria, Yanez, Patricio Eduardo, Huang, Yi-Hsiu, Begbie, Stephen, Rey, Felipe, Kramer, Gero, Suzuki, Hiroyoshi, Saretsky, Todd L., Ghate, Sameer R., Cui, Yi, Kim, Jeri, Yu, Evan Y.
Published in Journal of clinical oncology (20.02.2023)
Published in Journal of clinical oncology (20.02.2023)
Get full text
Journal Article
A phase II trial of nivolumab followed by ipilimumab and nivolumab in advanced non‐clear‐cell renal cell carcinoma
Conduit, Ciara, Davis, Ian D., Goh, Jeffrey C., Kichenadasse, Ganessan, Gurney, Howard, Harris, Carole A., Pook, David, Krieger, Laurence, Parnis, Francis, Underhill, Craig, Adams, Diana, Roncolato, Felicia, Joshua, Anthony, Ferguson, Tom, Prithviraj, Prashanth, Morris, Michelle, Harrison, Michelle, Begbie, Stephen, Hovey, Elizabeth, George, Mathew, Liow, Elizabeth C., Link, Emma K., McJannett, Margaret, Gedye, Craig
Published in BJU international (01.02.2024)
Published in BJU international (01.02.2024)
Get full text
Journal Article
Sequential immunotherapy in rare variant renal cell carcinomafinal report of UNISoN (ANZUP 1602): Nivolumab then ipilimumab + nivolumab in advanced nonclear cell renal cell carcinoma
Conduit, Ciara, Kichenadasse, Ganessan, Harris, Carole A., Gurney, Howard, Ferguson, Tom, Parnis, Francis, Goh, Jeffrey C., Morris, Michelle Frances, Underhill, Craig, Pook, David William, Davis, Ian D., Roncolato, Felicia, Harrison, Michelle L., Begbie, Stephen, Joshua, Anthony M., Link, Emma, Hovey, Elizabeth J., Gedye, Craig
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Elective hepatic resection is feasible and safe in a regional centre
Gray, Andrew D., Petrou, George, Rastogi, Pratik, Begbie, Stephen
Published in ANZ journal of surgery (01.03.2018)
Published in ANZ journal of surgery (01.03.2018)
Get full text
Journal Article
Ipilimumab + nivolumab in people with rare variant renal cell carcinoma refractory to nivolumab alone: Part 2 of UNISON (ANZUP 1602) nivolumab then ipilimumab + nivolumab in advanced non-clear cell renal cell carcinoma
Gedye, Craig, Pook, David William, Krieger, Laurence Eliot Miles, Harris, Carole A., Goh, Jeffrey C., Kichenadasse, Ganessan, Gurney, Howard, Underhill, Craig, Parnis, Francis, Joshua, Anthony M., Ferguson, Tom, Roncolato, Felicia, Harrison, Michelle L., Begbie, Stephen, Morris, Michelle Frances, Hovey, Elizabeth J., George, Mathew, Prithviraj, Prashanth, Link, Emma, Davis, Ian D.
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
CTIM-24. NUTMEG: A RANDOMIZED PHASE II STUDY OF NIVOLUMAB AND TEMOZOLOMIDE VERSUS TEMOZOLOMIDE ALONE IN NEWLY DIAGNOSED ELDERLY PATIENTS WITH GLIOBLASTOMA
Sim, Hao-Wen, Lwin, Zarnie, Barnes, Elizabeth, McDonald, Kerrie, Yip, Sonia, Verhaak, Roel, Heimberger, Amy, Hall, Merryn, Wong, Matthew, Jennens, Ross, Ashley, David, Rosenthal, Mark, Hovey, Elizabeth, Ellingson, Benjamin, Tognela, Annette, Gan, Hui, Back, Michael, Koh, Eng-Siew, Long, Anne, Cuff, Katharine, Begbie, Stephen, Gedye, Craig, Mislang, Anna, Le, Hien, Johnson, Margaret, Kong, Benjamin, Simes, John, Khasraw, Mustafa
Published in Neuro-oncology (Charlottesville, Va.) (14.11.2022)
Published in Neuro-oncology (Charlottesville, Va.) (14.11.2022)
Get full text
Journal Article
UNISON - nivolumab then ipilimumab + nivolumab in advanced non-clear cell renal cell carcinoma (ANZUP 1602): Part 1—Nivolumab monotherapy
Gedye, Craig, Pook, David William, Krieger, Laurence Eliot Miles, Harris, Carole A., Goh, Jeffrey C., Kichenadasse, Ganessan, Gurney, Howard, Underhill, Craig, Parnis, Francis, Joshua, Anthony M., Ferguson, Tom, Roncolato, Felicia, Harrison, Michelle L., Begbie, Stephen, Morris, Michelle Frances, Hovey, Elizabeth J., George, Mathew, Prithviraj, Prashanth, Liow, Elizabeth Chien Hern, Davis, Ian D.
Published in Journal of clinical oncology (20.02.2021)
Published in Journal of clinical oncology (20.02.2021)
Get full text
Journal Article
UNISON: Nivolumab then ipilimumab + nivolumab in advanced nonclear cell renal cell carcinoma (ANZUP 1602)
Gedye, Craig, Pook, David William, Krieger, Laurence Eliot Miles, Harris, Carole A., Goh, Jeffrey C., Kichenadasse, Ganessan, Gurney, Howard, Underhill, Craig, Parnis, Francis, Joshua, Anthony M., Ferguson, Thomas, Roncolato, Felicia, Harrison, Michelle L., Morris, Michelle Frances, Begbie, Stephen, Hovey, Elizabeth J., George, Mathew, Prithviraj, Prashanth, Liow, Elizabeth Chien Hern, Davis, Ian D.
Published in Journal of clinical oncology (20.02.2020)
Published in Journal of clinical oncology (20.02.2020)
Get full text
Journal Article
Mapping oncology services in regional and rural Australia
Underhill, Craig, Bartel, Rebecca, Goldstein, David, Snodgrass, Helen, Begbie, Stephen, Yates, Patsy, White, Kate, Jong, Kathy, Grogan, Paul
Published in The Australian journal of rural health (01.12.2009)
Published in The Australian journal of rural health (01.12.2009)
Get full text
Journal Article
Real-World Treatment and Outcomes of Metastatic Colorectal Cancer Patients With a Poor or Very Poor Performance Status
Travers, Avraham, Jalali, Azim, Begbie, Stephen, Semira, Christine, Kosmider, Suzanne, Ananda, Sumitra, Wong, Rachel, Lee, Margaret, Shapiro, Jeremy, Burge, Matthew, Yip, Desmond, Torres, Javier, Ma, Brigette, Nott, Louise, Dean, Andrew, Tie, Jeanne, Khattak, Adnan, Lim, Stephanie, Wong, Hui-li, Gibbs, Peter
Published in Clinical colorectal cancer (01.03.2021)
Published in Clinical colorectal cancer (01.03.2021)
Get full text
Journal Article